
Market expert Raja Venkatraman from NeoTrader has identified three stocks for trading on September 18, 2026, as Indian equities ended largely flat amid global headwinds. According to latest reports, Indian equities ended largely flat as bargain buying after the recent selloff was offset by global headwinds from the US Federal Reserve's rate hike, hawkish commentary, and elevated crude prices. The Nifty 50 rose 0.23% to 23,270.6, while the Sensex slipped 0.03% to 74,314.59, after swinging higher intraday. The spotlight was on the ₹2.3 billion IPO of the National Stock Exchange, India's largest bourse, which opened for bidding and drew 36% subscription by mid-afternoon, making it the country's third-largest listing ever. Sectoral breadth was positive with 12 of 16 major indices advancing, while small-cap and mid-cap indices gained 0.8% and 0.9% respectively.
JUBLFOOD, trading at ₹480.20, is recommended as a buy above ₹485 with stop loss at ₹463 and target price of ₹525 within 2 months. As reported by NeoTrader, Jubilant FoodWorks Limited is India's largest food service company, operating an extensive network of quick-service and homegrown restaurant brands across multiple countries. There has been a constant attempt at recovery and the recent pullback saw some buying interest develop, with the FMCG sector seen reviving and Macquaire upgrading the stock in the last month indicating a promising future outlook. The news of preference shares has triggered renewed interest as volumes have picked up, suggesting more upward traction. The stock shows P/E ratio of 129.98, 52-week high of ₹635 with 817.23K volume, and technical analysis indicates support at ₹450 and resistance at ₹700.
PFOCUS, trading at ₹334.95, is recommended as a buy above ₹337 with stop loss at ₹318 and target price of ₹367 within 2 months. According to NeoTrader, Prime Focus Limited is an Indian-headquartered, world-leading independent integrated media services company that provides end-to-end creative and technical services to the global media and entertainment industry. The steady upward traction with prices moving higher and forming higher lows, along with strong action with volumes seen on Thursday, highlights potential for upward movement. A move above the value area region around 310 holding good indicates continued upward drive. The stock shows 52-week high of ₹367 with 6.59M volume, and technical analysis indicates support at ₹295 and resistance at ₹400.
TATVA, trading at ₹1,709.60, is recommended as a buy above ₹1,715 with stop loss at ₹1,605 and target price of ₹1,885 within 2 months. As reported by NeoTrader, Tatva Chintan Pharma Chem Limited is an integrated, India-based specialty chemical manufacturer operating as a global supplier, exporting approximately 62% of its products. Since July 2026, the stock has formed a nice rounding bottom at lower levels, forming a base from the lower levels. After a strong push, the recovery with volumes signals a potential revival, highlighting some fresh momentum. Strong domestic demand and higher gas prices have shifted focus to organized players, with recent revival indicating fresh momentum. The stock shows P/E ratio of 90.08, 52-week high of ₹1,838.10 with 89.93K volume, and technical analysis indicates support at ₹1,470 and resistance at ₹1,950.
The latest market data shows Brent crude above $100 per barrel and elevated U.S. Treasury yields near 5%, adding to global risk aversion. Among Sensex constituents, Tata group stocks outperformed with Tata Motors, Tata Steel, and Tata Investment rallying between 2.3% and 5.5% after the board of Tata Sons approved a fresh five-year term for Chairman N. Chandrasekaran. Traders noted short-covering from oversold levels, though sentiment remained cautious amid tight global monetary conditions and oil above $100 a barrel. Expiry-related volatility was contained as regulators' proposed changes to derivatives settlement were seen as supportive, with sectoral breadth positive across most segments. Technical analysis indicates the Nifty struggling to hold above 23,000, which represents both the last stop for bullish revival and the maximum pain point, with analysts expecting continued consolidation as the index attempts to move out of a ranging action.